Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - PHOENIX MEDICAL SOFTWARE, INC.Financial_Report.xls
EX-31.1 - CERTIFICATION - PHOENIX MEDICAL SOFTWARE, INC.ex31one.htm
EX-32.1 - CERTIFICATION - PHOENIX MEDICAL SOFTWARE, INC.ex32one.htm
EX-31.2 - CERTIFICATION - PHOENIX MEDICAL SOFTWARE, INC.ex31two.htm

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q/A

 

 

(Mark One)

 

[ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2011

 

OR

 

[    ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934

 

From the transition period from ___________ to ____________.

 

Commission File Number 000-51750

 

PHOENIX MEDICAL SOFTWARE, INC.

(Exact name of small business issuer as specified in its charter)

 

  Nevada   20-4846807
(State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.)

 

604 Creekview, Ovilla, Texas 75154

(Address of principal executive offices)

 

  (800) 843-8179

(Issuer's telephone number)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:.  Yes [ X ]   No [     ].

 

Indicate by a check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” ”accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

  Large Accelerated Filer [   ]   Accelerated Filer [  ]
       
  Non-Accelerated Filer   [   ]   Smaller Reporting Company [X]

 

Indicate by a check mark whether the company is a shell company (as defined by Rule 12b-2 of the Exchange Act:  Yes [   ]   No [X].

 

As of August 15, 2011 there were 9,513,667 shares of Common Stock of the issuer outstanding.

 

 
 

 

EXPLANATORY NOTE

 

The purpose of this Form 10-Q/A to Phoenix Medical Software, Inc.'s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011, filed with the Securities and Exchange Commission on August 15, 2011 (the "Form 10-Q"), is solely to include the XBRL.

 

No other changes have been made to the Form 10-Q previously filed. This Amendment speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date and does not modify or update in any way disclosures made in the original Form 10-Q.

 

In addition, pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as a result of this Amended Report, the certifications pursuant to Section 302 and Section 906 of the Sarbanes-Oxley Act of 2002, filed and furnished, respectively as exhibits to the Original Report have been re-executed and re-filed as of the date of this Amended Report and are included as exhibits hereto.

 
 

 

SIGNATURES

 

In accordance with the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

PHOENIX MEDICAL SOFTWARE, INC.

 

By /s/ P. Morgan McCune

 

P. Morgan McCune, President, CFO

 

Date: September 12, 2011